Trial: NCT06372145 — Sanofi
**Who might be able to join this trial:** - You have a form of multiple sclerosis (relapsing MS, primary progressive MS, or non-relapsing secondary progressive MS) and you previously completed a related earlier clinical trial (Phase 2b or...